oral selective PI3K_ kinase inhibitor
<10 mg proj. human dose
from virtual screening and opt.
ACS Med. Chem. Lett., Nov. 19, 2020
Merck, Boston, CA
“compound 4d”
1 min read
“compound 4d” (Merck oral selective PI3K delta kinase inhibitor)
Search By Structure
- LY3502970
- S64315
- daridorexant
- “peptide 78”
- BMS-986144
- MLT-985
- EB-42486
- “compound 4d”
- “compound 60b”
- “compound 15a”
- “compound 31”
- “compound 36”
- BCPyr
- “compound 4j”
Molecules of the Month
2023
2022
2021
2020